Dose finding of melatonin for chronic idiopathic childhood sleep onset insomnia: an RCT
Open Access
- 29 July 2010
- journal article
- research article
- Published by Springer Nature in Psychopharmacology
- Vol. 212 (3) , 379-391
Abstract
Rationale Pharmacokinetics of melatonin in children might differ from that in adults. Objectives This study aims to establish a dose–response relationship for melatonin in advancing dim light melatonin onset (DLMO), sleep onset (SO), and reducing sleep onset latency (SOL) in children between 6 and 12 years with chronic sleep onset insomnia (CSOI). Methods The method used for this study is the randomized, placebo-controlled double-blind trial. Children with CSOI (n = 72) received either melatonin 0.05, 0.1, and 0.15 mg/kg or placebo during 1 week. Sleep was assessed with log and actigraphy during this week and the week before. Outcomes were the shifts in DLMO, SO, and SOL. Results Treatment with melatonin significantly advanced SO and DLMO by approximately 1 h and decreased SOL by 35 min. Within the three melatonin groups, effect size was not different, but the circadian time of administration (TOA) correlated significantly with treatment effect on DLMO (r s = −0.33, p = 0.022) and SO (r s = −0.38, p = 0.004), whereas clock TOA was correlated with SO shift (r = −0.35, p = 0.006) and not with DLMO shift. Conclusions No dose–response relationship of melatonin with SO, SOL, and DLMO is found within a dosage range of 0.05–0.15 mg/kg. The effect of exogenous melatonin on SO, SOL, and DLMO increases with an earlier circadian TOA. The soporific effects of melatonin enhance the SO shift. This study demonstrates that melatonin for treatment of CSOI in children is effective in a dosage of 0.05 mg/kg given at least 1 to 2 h before DLMO and before desired bedtime.Keywords
This publication has 46 references indexed in Scilit:
- A three pulse phase response curve to three milligrams of melatonin in humansThe Journal of Physiology, 2008
- A randomized, placebo‐controlled trial of controlled release melatonin treatment of delayed sleep phase syndrome and impaired sleep maintenance in children with neurodevelopmental disabilitiesJournal of Pineal Research, 2007
- Melatonin Treatment in Adolescents With Delayed Sleep Phase SyndromeClinical Pediatrics, 2006
- Rational prescribing for childrenBMJ, 2006
- A farewell to Bonferroni: the problems of low statistical power and publication biasBehavioral Ecology, 2004
- Melatonin in wake–sleep disorders in children, adolescents and young adults with mental retardation with or without epilepsy: a double-blind, cross-over, placebo-controlled trialBrain and Development, 2004
- Melatonin in wake?sleep disorders in children, adolescents and young adults with mental retardation with or without epilepsy: a double-blind, cross-over, placebo-controlled trialBrain and Development, 2004
- Melatonin for Chronic Sleep Onset Insomnia in Children: A Randomized Placebo-Controlled TrialJournal of Child Neurology, 2001
- Sleep Disturbances in Children with Attention-Deficit/Hyperactivity DisorderJournal of Learning Disabilities, 1998
- Electrophysiology of Postsynaptic ActivationaAnnals of the New York Academy of Sciences, 1998